Borosil Scientific holds 35th AGM, approves fund raise and CEO reappointment
- Borosil Scientific held its 35th AGM on September 25, 2026, via Video Conference
- Shareholders approved the raising of funds through equity share issuance
- Vinayak Madhukar Patankar was re-appointed as Whole-time Director & CEO
- Material related party transactions with Borosil Limited were approved
- Amendments to Employee Stock Option Schemes were passed via special resolution

*this image is generated using AI for illustrative purposes only.
Borosil Scientific Limited held its 35th Annual General Meeting on September 25, 2026, through Video Conference and Other Audio-Visual Means. The meeting addressed the adoption of financial statements for FY26 and several special business items.
The AGM commenced at 11:00 am and concluded at 12:09 pm. Kewal Kundanlal Handa, Independent Director and Chairman of the Board, chaired the session. All Board members, senior management, and representatives of the Statutory Auditor were present. The meeting was conducted in compliance with the Companies Act, 2013, and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Ordinary business resolutions
Shareholders considered the audited standalone and consolidated financial statements for the financial year ended March 31, 2026. The Board of Directors' reports and Statutory Auditor's reports were also adopted. Additionally, Pradeep Kumar Kheruka was re-appointed as a director retiring by rotation.
Special business and strategic approvals
The meeting focused significantly on governance and capital structure updates. Members voted on material related party transactions with Borosil Limited and the re-appointment of Vinayak Madhukar Patankar as Whole-time Director & CEO. A special resolution was also passed regarding his remuneration.
Key strategic approvals included:
- Raising funds by way of issuance of Equity Shares or Securities
- Amendments to Employee Stock Option Schemes
- Secondary acquisition of shares through Trust route for ESOP implementation
- Provision of money for purchase of own shares by the Trust under ESOPs
Voting and compliance details
Remote e-voting commenced on September 22, 2026, at 9:00 am and concluded on September 24, 2026, at 5:00 pm. E-voting facilities were also available during the live AGM session. Dhrumil M. Shah served as the scrutiniser to ensure a fair and transparent voting process. The e-voting results and the Consolidated Scrutiniser's Report will be intimated separately and placed on company and exchange websites.
Historical Stock Returns for BOROSCI
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.19% | -2.32% | -8.50% | +11.60% | -15.88% | -26.26% |
How will the approved equity issuance impact Borosil Scientific's capital structure and dilution for existing shareholders?
What specific growth initiatives or capacity expansions are targeted by the funds raised through the new securities issuance?
How might the amendments to the Employee Stock Option Schemes influence employee retention and operational efficiency in the coming fiscal year?

































